An Inflammation-Immunity Classifier of 11 Chemokines for Prediction of Overall Survival in Head and Neck Squamous Cell Carcinoma.
CONCLUSIONS This 11-chemokine signature could serve as a reliable prognostic tool for HNSC patients and might be useful to guide individualized treatment or even gene target therapy for high-risk patients.
PMID: 31203306 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Carcinoma | Databases & Libraries | Genetics | Head and Neck Cancer | HNSCC | Research | Science | Skin Cancer | Squamous Cell Carcinoma | Training | Universities & Medical Training